Alzheimers Research

Registration of Clinical Trials

Serious Alzheimers research is being conducted worldwide, and in the United States all clinical trials must be registered with the government. Many of these clinical trials are being carried out at government funded research programs called Alzheimer’s Disease Research Centers (ADCs).

Alzheimers Research has awarded more than $71 million to support promising Alzheimer's Disease research in fields ranging from molecular biology to epidemiology.

Altzheimers Research is currently supporting 62 outstanding biomedical researchers.

There is a long list of 801 studies with Alzheimer’s Disease research.

Please click here to read more about: Alzheimers Disease Research:
Other areas of Alzheimers Disease research may seem to be less directly related to prevention, but their findings, too, may someday lead to successful prevention interventions.

Here you'll find more about Alzheimers Disease Stem Cell Research.
Medical researchers believe that someday, Alzheimers Disease stem cell studies may lead to insights into Alzheimer's.

Examples of Alzheimers Research Projects

Below an at random list with 20 of Alzheimers research projects.

1. Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training - Intervention: Behavioral: Individualized management of Alzheimers Disease including caregiver training; Drug: Memantine
2. Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease - Intervention: Genetic: CERE-110: Adeno-Associated Virus Delivery of NGF; Procedure: Placebo Surgery
3. Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's Disease - Intervention: Drug: Varenicline; Drug: Placebo
4. Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease - Intervention: Biological: PF-04360365 8.5 mg/kg; Drug: Placebo
5. Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type - Intervention: Drug: rivastigmine transdermal patch 15 cm2; Drug: rivastigmine transdermal patch 5 cm2
6. Alzheimer's Disease Genetics Study
7. Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo - Intervention: Drug: LY450139; Drug: Placebo
8. Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease - Intervention: Biological: PF-04360365 0.1 mg/kg; Biological: PF-04360365 0.5 mg/kg; Biological: PF-04360365 1 mg/kg; Drug: Placebo; Biological: PF-04360365 3 mg/kg; Biological: PF-04360365 8.5 mg/kg
9. Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease - Intervention: Drug: ST101; Drug: Placebo
10. Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease - Intervention: Drug: Bryostatin for Injection; Drug: Placebo
11. Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease - Intervention: Drug: ST101; Drug: Placebo
12. Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease - Intervention: Drug: EVP-6124; Drug: Placebo
13. Functional Magnetic Resonance Imaging - Synthetic Aperture Magnetometry (fMRI-SAM) and Alzheimer's Disease - Intervention: Procedure: fMRI to detect MCI patients who will convert to Alzheimer's Disease
14. Life From Vision in Alzheimer Disease - Intervention: Behavioral: Questionaries
15. Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II - Intervention:
16. Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease - Intervention: Drug: atomoxetine hydrochloride; Drug: placebo
17. Study of the Effect of Repetitive Transcranial Magnetic Stimulation on Language in Patients With Alzheimer's Disease - Intervention: Device: Repetitive Transcranial Magnetic Coil Stimulation (rTMS)
18. European Study of HF0220 in Mild to Moderate Alzheimer's Disease Patients - Intervention: Drug: HF0220
19. Randomized Trial of a Nutritional Supplement in Alzheimer's Disease - Intervention: Dietary Supplement: Resveratrol with Glucose, and Malate; Dietary Supplement: Placebo
20. Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease. An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease - Intervention: Drug: Galantamine; Placebo

From Alzheimers Research, back to the Homepage